Figure 2.
IgG, IgM and IgA reactivity against SAc-BSA, 2OA-BSA, and BSA of AIH patients (n=95), AMA-negative PBC patients (n=20), AMA-positive PBC patients (n=155), PSC patients (n=86), and normal subjects (n=60). Data presented as mean ± SEM. Asterisks indicate significant differences as compared to the reactivity of AMA-positive PBC patients against SAc-BSA (***, p < 0.0001; two-tailed unpaired t-test with Welch’s correction).